TABLE 6.
Odds ratio | 95% CI | P value | |
---|---|---|---|
Wound severity grade | 1.97 | 1.42‐2.73 | <.001 * |
Age (y) | 0.96 | 0.90‐1.02 | .19 |
Sex | |||
Male | Baseline | ||
Female | 0.95 | 0.62‐1.44 | .81 |
Neuter status | |||
Entire | Baseline | ||
Neutered | 0.89 | 0.55‐1.44 | .63 |
Weight | .87 | ||
<10 kg | Baseline | ||
10‐25 kg | 0.99 | 0.57‐1.77 | .99 |
25+ kg | 0.81 | 0.44‐1.48 | .49 |
Unknown | 0.96 | 0.51‐1.82 | .91 |
Clinic | <.001 * | ||
Clinic C | Baseline | ||
Clinic B (low‐importance vs high‐importance antimicrobials) | 1.21 | 0.44‐3.32 | .72 |
Clinic B (medium‐importance vs high‐importance antimicrobials) | 0.18 | 0.08‐0.41 | <.001* |
Clinic A | 1.10 | 0.61‐1.98 | .75 |
Year of consultation | <.001 * | ||
1999‐2004 | Baseline | ||
2005‐2009 (low‐importance vs high‐importance antimicrobials) | 5.73 | 2.00‐16.40 | .001* |
2005‐2009 (medium‐importance vs high‐importance antimicrobials) | 2.11 | 0.86‐5.18 | .10 |
2010‐2014 | 5.23 | 2.41‐11.35 | <.001* |
2015‐2019 | 4.23 | 1.81‐9.86 | .001* |
Type of therapy | |||
Monotherapy | Baseline | ||
Polytherapy | 18.93 | 9.61‐37.33 | <.001 * |
C&S performed | |||
Not performed | Baseline | ||
Performed | 1.93 | 0.57‐6.53 | .29 |
Time of attack | .71 | ||
<8 h | Baseline | ||
≥8 h | 0.76 | 0.38‐1.49 | .42 |
Unknown | 0.86 | 0.49‐1.50 | .59 |
Season of attack | .44 | ||
Spring | Baseline | ||
Summer | 1.25 | 0.69‐2.27 | .46 |
Autumn | 0.85 | 0.44‐1.48 | .62 |
Winter | 1.34 | 0.51‐1.82 | .34 |
Duration of hospitalization (days) | 1.15 | 1.05‐1.27 | .004 * |
Significant at the .05 level. The P values for the individual levels of the categorical variables compared to the baseline are given, in addition to a bolded P value for all levels of that categorical variable combined.